International Workshop on HIV & Pediatrics 2015

Slideset

HIV

TDF Use Across the Age Spectrum: From Fetus to Adolescent - Anna Turkova, MD

Slideset

HIV

Debate: CD4 Assays Are No Longer Needed for Care of Children in Lowresource Countries - Ted Ruel, MD

Slideset

HIV

CON ‐ standpoint - Diana Gibb, MD, MRCP, MSc

Slideset

HIV

Pediatric Treatment Cascade: What Do We Need to Reach “90‐90‐90” for Children - Elaine Abrams, MD

Slideset

HIV

Virologic Outcomes of Children Switched from Lopinavir/Ritonavir‐ to Efavirenz‐Based Antiretroviral Treatment: a retrospective cohort study - Kirsten Reichmuth

Slideset

HIV

Lopinavir ritonavir (1:1 ratio) in the presence of rifampicin is not inferior to lopinavir ritonavir (4:1 ratio) in the absence of rifampicin in HIV children. Interim analysis of an open label sequential non- randomized phar- Mark Cotton

Slideset

HIV

The effect of systemic exposure to efavirenz, sex and age on the risk of virological non‐suppression in HIV‐infected African children - Andrzej Bienczak

Slideset

HIV

Durability of first‐line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) - Ruth Goodall

Slideset

HIV

Reasons for delayed ART initiation in children with HIV in South Africa - Chloe Teasdale

Slideset

HIV

Efavirenz‐based therapy may simplify antiretroviral LPV‐based therapy initiated in HIV‐1‐infected children before the age of 2 in West‐Africa: the MONOD trial ANRS 12206 - Valeriane Leroy

Slideset

HIV

Bridging Worlds: Perinatally‐Infected Youth and Transition to Adult Care - Caroline Foster, MBBS, MRCPCH

Slideset

HIV

Anxiety and depression in young people with perinatal HIV and their HIV negative siblings - Marthe Le Prevost

Slideset

HIV

Innovative Adherence Interventions for HIV‐Infected Youth - Rachel Vreeman, MD, MS

Slideset

HIV

Hepatitis B Treatment Response to TDF in 3TC‐experienced Perinatally HIVinfected Adolescents - Linda Aurpibul

Slideset

HIV

Prevalence and Associated Factors of Nonalcoholic Fatty Liver Disease and Liver Fibrosis among Perinatally HIV‐infected Asian Adolescents - Tavitiya Sudjaritruk

Slideset

HIV

Week 48 safety and efficacy of a rilpivirine (TMC278)‐based regimen in HIVinfected treatment‐naïve adolescents: PAINT Phase II trial - Patricia Flynn

Slideset

HIV

Second‐line ART treatment and resistance outcomes of Asian children - Annette Sohn, MD

Slideset

HIV

Overview lecture on Pros and Cons - Lynne Mofenson, MD

Slideset

HIV

PRO ‐ standpoint - Jennifer Jao, MD, MPH

Slideset

HIV

Debate: HIV‐Exposed Uninfected Infants Require Lifelong Follow Up in All - Thanyawee Puthanakit, MD

Slideset

HIV

HIV exposed uninfected South African infants experience greater severity but not frequency of common infectious diseases than HIV unexposed uninfected infants - Amy Slogrove

Slideset

HIV

Effectiveness of conditional cash transfers to increase retention in care and adherence to PMTCT services: A randomized controlled trial - Marcel Yotebieng

Slideset

HIV

Psychosocial factors in younger versus older HIV‐infected pregnant women initiating antiretroviral therapy in Cape Town, South Africa - Marcia Wong

Slideset

HIV

In utero Tenofovir Exposure is Not Associated with Poor Fetal Long Bone Growth - Jennifer Jao

Slideset

HIV

Controversies in TB Meningitis - Kelly Dooley, MD, PhD

Slideset

HIV

Hepatitis C virus Infection in Children with and without HIV ‐ Epidemiologynsmission (MTCT) of HIV during Breastfeeding (BF) - Claire Thorne, BA, MSc, PhD

Slideset

HIV

Hearing Loss in HIV‐Infected Children in Lilongwe, Malawi - Susan Hrapcak, MD

Slideset

HIV

Hepatitis C virus infection in children with and without HIV ‐ Treatment - Giuseppe Indolfi, MD, PhD

Slideset

HIV

Changes in renal laboratory parameters and bone mineral density in treatment‐naïve HIV‐1‐infected adolescents initiating E/C/F/TAF or E/C/F/TDF - Sean Bennett

Slideset

HIV

Lower immune response in HIV‐positive girls to the quadrivalent human papillomavirus vaccine - Jason Brophy, MD

Slideset

HIV

Decreased bone mass in perinatally HIV‐infected school‐aged South African children on antiretrovirals - Stephanie Shiau

Slideset

HIV

Early cardio‐pulmonary disease in children despite early ART ‐ Evidence from CHER cohort - Steve Innes

Slideset

HIV

International Workshop on HIV & Pediatrics 2015

TDF Use Across the Age Spectrum: From Fetus to Adolescent - Anna Turkova, MD

Debate: CD4 Assays Are No Longer Needed for Care of Children in Lowresource Countries - Ted Ruel, MD

CON ‐ standpoint - Diana Gibb, MD, MRCP, MSc

Pediatric Treatment Cascade: What Do We Need to Reach “90‐90‐90” for Children - Elaine Abrams, MD

Virologic Outcomes of Children Switched from Lopinavir/Ritonavir‐ to Efavirenz‐Based Antiretroviral Treatment: a retrospective cohort study - Kirsten Reichmuth

Lopinavir ritonavir (1:1 ratio) in the presence of rifampicin is not inferior to lopinavir ritonavir (4:1 ratio) in the absence of rifampicin in HIV children. Interim analysis of an open label sequential non- randomized phar- Mark Cotton

The effect of systemic exposure to efavirenz, sex and age on the risk of virological non‐suppression in HIV‐infected African children - Andrzej Bienczak

Durability of first‐line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) - Ruth Goodall

Reasons for delayed ART initiation in children with HIV in South Africa - Chloe Teasdale

Efavirenz‐based therapy may simplify antiretroviral LPV‐based therapy initiated in HIV‐1‐infected children before the age of 2 in West‐Africa: the MONOD trial ANRS 12206 - Valeriane Leroy

Bridging Worlds: Perinatally‐Infected Youth and Transition to Adult Care - Caroline Foster, MBBS, MRCPCH

Anxiety and depression in young people with perinatal HIV and their HIV negative siblings - Marthe Le Prevost

Innovative Adherence Interventions for HIV‐Infected Youth - Rachel Vreeman, MD, MS

Hepatitis B Treatment Response to TDF in 3TC‐experienced Perinatally HIVinfected Adolescents - Linda Aurpibul

Prevalence and Associated Factors of Nonalcoholic Fatty Liver Disease and Liver Fibrosis among Perinatally HIV‐infected Asian Adolescents - Tavitiya Sudjaritruk

Week 48 safety and efficacy of a rilpivirine (TMC278)‐based regimen in HIVinfected treatment‐naïve adolescents: PAINT Phase II trial - Patricia Flynn

Second‐line ART treatment and resistance outcomes of Asian children - Annette Sohn, MD

Overview lecture on Pros and Cons - Lynne Mofenson, MD

PRO ‐ standpoint - Jennifer Jao, MD, MPH

Debate: HIV‐Exposed Uninfected Infants Require Lifelong Follow Up in All - Thanyawee Puthanakit, MD

HIV exposed uninfected South African infants experience greater severity but not frequency of common infectious diseases than HIV unexposed uninfected infants - Amy Slogrove

Effectiveness of conditional cash transfers to increase retention in care and adherence to PMTCT services: A randomized controlled trial - Marcel Yotebieng

Psychosocial factors in younger versus older HIV‐infected pregnant women initiating antiretroviral therapy in Cape Town, South Africa - Marcia Wong

In utero Tenofovir Exposure is Not Associated with Poor Fetal Long Bone Growth - Jennifer Jao

Controversies in TB Meningitis - Kelly Dooley, MD, PhD

Hepatitis C virus Infection in Children with and without HIV ‐ Epidemiologynsmission (MTCT) of HIV during Breastfeeding (BF) - Claire Thorne, BA, MSc, PhD

Hearing Loss in HIV‐Infected Children in Lilongwe, Malawi - Susan Hrapcak, MD

Hepatitis C virus infection in children with and without HIV ‐ Treatment - Giuseppe Indolfi, MD, PhD

Changes in renal laboratory parameters and bone mineral density in treatment‐naïve HIV‐1‐infected adolescents initiating E/C/F/TAF or E/C/F/TDF - Sean Bennett

Lower immune response in HIV‐positive girls to the quadrivalent human papillomavirus vaccine - Jason Brophy, MD

Decreased bone mass in perinatally HIV‐infected school‐aged South African children on antiretrovirals - Stephanie Shiau

Early cardio‐pulmonary disease in children despite early ART ‐ Evidence from CHER cohort - Steve Innes

Computerized cognitive rehabilitation training can improve neuropsychological outcomes in rural school‐age Ugandan children with HIV - Michael Boivin